We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$133B
AUM Growth
+$2.97B
(+2.3%)
Cap. Flow
+$494M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
28.35%
Holding
293
New
7
Increased
75
Reduced
134
Closed
7
Avg Time Held
3.4
years
Top 10 Avg Time Held
3.7
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$635M |
| 2 |
United Airlines
UAL
|
+$620M |
| 3 |
Qualcomm
QCOM
|
+$401M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$302M |
| 5 |
Whirlpool
WHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$442M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$411M |
| 3 |
Adobe
ADBE
|
+$359M |
| 4 |
Texas Instruments
TXN
|
+$345M |
| 5 |
AT&T
T
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.7% |
| 2 | Healthcare | 23.28% |
| 3 | Industrials | 16.25% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Financials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
NMI Holdings
NMIH
$3.06B
| $12M | 0.01% |
726,810
+676,810
| +1,354% | +$12.6M |
2017 Q4
1 quarter
|
|
227
Autodesk
ADSK
$50.1B
| $10.8M | 0.01% |
86,000
+70,900
| +470% | +$8.44M |
2017 Q4
1 quarter
|
|
228
Somnigroup International
SGI
$14.6B
| $10.4M | 0.01% |
922,000
+400,000
| +77% | +$5.49M |
2016 Q4
5 quarters
|
|
229
DELISTED
Diebold Nixdorf Incorporated
DBD
| $10.4M | 0.01% |
675,000
| – | – |
2013 Q2
19 quarters
|
|
230
Digimarc Corp
DMRC
$151M
| $9.89M | 0.01% |
413,000
| – | – |
2015 Q3
10 quarters
|
|
231
Decoy Therapeutics
DCOY
$767K
| $9.06M | 0.01% |
2
| – | – |
2015 Q1
12 quarters
|
|
|
COL
232
DELISTED
Rockwell Collins
COL
| $8.89M | 0.01% |
65,900
| – | – |
2017 Q1
4 quarters
|
|
233
Constellation Brands
STZ
$22.2B
| $8.78M | 0.01% |
38,536
| – | – |
2017 Q2
3 quarters
|
|
|
TUES
234
DELISTED
Tuesday Morning Corp
TUES
| $8.73M | 0.01% |
2,209,000
| – | – |
2013 Q2
19 quarters
|
|
235
Acuity Brands
AYI
$9.08B
| $7.93M | 0.01% |
57,000
+1,500
| +3% | +$231K |
2017 Q4
1 quarter
|
|
236
Chubb
CB
$139B
| $7.67M | 0.01% |
56,079
| – | – |
2016 Q1
8 quarters
|
|
237
Allegiant Air
ALGT
$1.83B
| $7.51M | 0.01% |
43,500
| – | – |
2013 Q2
19 quarters
|
|
238
ExxonMobil
XOM
$736B
| $7.09M | 0.01% |
95,000
| – | – |
2013 Q2
19 quarters
|
|
239
Cabot Corp
CBT
$3.84B
| $6.96M | 0.01% |
125,000
| – | – |
2013 Q2
19 quarters
|
|
240
Adient
ADNT
$1.38B
| $6.79M | 0.01% |
113,570
| – | – |
2016 Q4
5 quarters
|
|
241
ICF International
ICFI
$1.6B
| $6.69M | 0.01% |
+114,419
| New | +$6.45M |
2018 Q1
0 quarters
|
|
242
Gibraltar Industries
ROCK
$1.12B
| $6.68M | 0.01% |
197,500
+95,200
| +93% | +$3.31M |
2017 Q4
1 quarter
|
|
243
Penumbra
PEN
$12.6B
| $6.63M | 0.01% |
57,330
-100
| -0.2% | -$10.3K |
2015 Q3
10 quarters
|
|
244
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $6.37M | ﹤0.01% |
360,000
-115,000
| -24% | -$2.03M |
2013 Q4
17 quarters
|
|
245
Matsons
MATX
$7.03B
| $5.72M | ﹤0.01% |
199,761
| – | – |
2014 Q3
14 quarters
|
|
246
Glaukos
GKOS
$9.72B
| $5.61M | ﹤0.01% |
182,000
+99,790
| +121% | +$3.02M |
2017 Q4
1 quarter
|
|
|
MBII
247
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $5.25M | ﹤0.01% |
2,625,600
| – | – |
2013 Q3
18 quarters
|
|
248
DELISTED
Comerica
CMA
| $5.13M | ﹤0.01% |
53,500
| – | – |
2013 Q2
19 quarters
|
|
249
Greif
GEF
$4.67B
| $3.92M | ﹤0.01% |
75,000
-5,000
| -6% | -$282K |
2013 Q2
19 quarters
|
|
|
250
AT&T
T
$161B
| $3.6M | ﹤0.01% |
133,735
-10,201,625
| -99% | -$284M |
2015 Q3
10 quarters
|
|
Similar funds
Primecap Management's Q1 2018 Portfolio in Review
As of Q1 2018, Primecap Management held 293 positions worth $133B, up 2.3% from $130B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.8%. Primecap Management opened 7 new positions and exited 7, leaving the 293-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2018 buy was Moody's: 181,000 shares worth $29.2M.
- Primecap Management added most to Bristol-Myers Squibb in Q1 2018, an estimated $635M increase.
- Primecap Management's biggest Q1 2018 reduction was NVIDIA, cutting an estimated $442M.
- Primecap Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $411M.
- Primecap Management's ten largest holdings make up 28% of its $133B portfolio in Q1 2018.
- Primecap Management opened 7 new positions and closed 7 in Q1 2018.
- Primecap Management's portfolio value rose 2.3% quarter-over-quarter to $133B.
Based on Primecap Management's 13F filing for Q1 2018, filed 14 May 2018.